Connect with us

EU

#EAPM2017: Personalising Your Health - A Global Imperative

SHARE:

Published

9 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Today (27 November) saw the opening of the first annual Congress held by the European Alliance for Personalised Medicine (EAPM).

The four-day Congress, entitled ‘Personalising Your Health: A Global Imperative’ is being held in the capital of Northern Ireland under the auspices of the Estonian Presidency of the EU and in association with Queen’s University Belfast and Visit Belfast.

This is the first ever pan-European, multidisciplinary Congress specific to the fast-moving field of personalised medicine. The event at the Belfast Waterfront venue will provide the biggest ‘space’ to date to allow for such a meeting of minds and expertise.

It represents a one-stop-shop for top-level discussion and the formulation of real action plans.

EAPM executive director Denis Horgan opened the inaugural Congress, saying: The Alliance brings together extensive scientific, clinical, caring and training expertise in personalised medicine and diagnostics.

"This involves patient groups, academia, health professionals and industry, while we also engage in ongoing dialogue with the European Commission, Parliament and the EMA.”

"I’m delighted to see that representatives from all of these areas are with us this week,” he added.

Advertisement

Christian Busoi MEP said: “Action is necessary at a cooperative and EU level - in gaining new insights into diseases, personalised medicine is already becoming the dominant therapy for cancer and a host of other afflictions.

“Quality assurance needs to be further developed to respond to patients requirements. And affordability is the most crucial issue - can we ‘afford’ to beat cancer?”

Mark Lawler said: “We must look at how to realise the promise of the patient-centred approach. Better methods of treatment and treatment education need to help the person at the level of the person.”

Desmond Shatz MD, of the UF Diabetes Institute said: “There is a sense of urgency and a call for action on diabetes - understanding the disease is key to personalised medicine treating it.

“Diabetes is the epidemic of the 21st century - at present, there are 415 million sufferers, with 620m projected by 2040. Treatment requirements are not being met by current methods.”

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending